• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

    7/20/23 8:04:02 AM ET
    $ABVC
    $AKU
    $ALPS
    $AULT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Health Care
    Get the next $ABVC alert in real time by email

    Gainers

    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.
    • PainReform Ltd. (NASDAQ:PRFX) shares gained 31.8% to $9.37 in pre-market trading after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.
    • Dynatronics Corporation (NASDAQ:DYNT) rose 17.3% to $0.9170 in pre-market trading.
    • BRF S.A. (NYSE:BRFS) gained 8.4% to $2.07 in pre-market trading after gaining around 4% on Wednesday.
    • Ault Alliance, Inc. (NYSE:AULT) shares rose 8% to $4.06 in pre-market trading after falling 8% on Wednesday.
    • Cosmos Health Inc. (NASDAQ:COSM) shares gained 7.7% to $2.67 in pre-market trading after declining 7% on Wednesday.
    • Cosmos Health Inc. (NASDAQ:COSM) rose 6.9% to $2.65 in pre-market trading after falling 7% on Wednesday.
    • ENGlobal Corporation (NASDAQ:ENG) shares rose 6.6% to $0.4470 in pre-market trading after gaining around 4% on Wednesday.
    • Nanobiotix S.A. (NASDAQ:NBTX) shares climbed 6.2% to $7.60 in pre-market trading as the company said first patient was injected in new Phase 1/2 study evaluating radiotherapy-activated NBTXR3 plus anti-PD-1 for patients with advanced cancers.
    • Puma Biotechnology, Inc. (NASDAQ:PBYI) gained 5.4% to $3.52 in pre-market trading.

    Losers

    • Netcapital Inc. (NASDAQ:NCPL) fell 40.8% to $0.6910 in pre-market trading after the company priced its public offering of 1.725 million shares at $0.70 per share.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) fell 14% to $0.3613 in pre-market trading.
    • Discover Financial Services (NYSE:DFS) fell 12.2% to $107.00 in pre-market trading after the company reported downbeat quarterly earnings and announced a share buyback pause.
    • Synlogic, Inc. (NASDAQ:SYBX) shares fell 11.8% to $0.46 in pre-market trading after gaining 4% on Wednesday.
    • JX Luxventure Limited (NASDAQ:JXJT) shares fell 10% to $2.33 in pre-market trading. JX Luxventure shares gained 11% on Wednesday after the company reported a new artificial intelligence initiative.
    • Richardson Electronics, Ltd. (NASDAQ:RELL) fell 9.3% to $14.09 in pre-market trading after the company reported worse-than-expected fourth-quarter earnings results.
    • Alpine Summit Energy Partners, Inc. (NASDAQ:ALPS) fell 8.6% to $0.1630 in pre-market trading after declining around 8% on Wednesday. The company recently filed for voluntary chapter 11 relief in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division.
    • Netflix, Inc. (NASDAQ:NFLX) fell 6.8% to $445.20 in pre-market trading. Netflix reported upbeat earnings for the second quarter, while sales missed expectations.
    • Akumin Inc. (NASDAQ:AKU) shares fell 6.8% to $0.1569 in pre-market trading after gaining 4% on Wednesday. Akumin recently appointed Krishna Kumar as President and Chief Operating Officer of the Company.
    • Tesla, Inc. (NASDAQ:TSLA) fell 3% to $282.49 in pre-market. Tesla reported better-than-expected earnings and sales results for its second quarter, but said operating margin narrowed to 9.6% from 14.6% in the year-ago period.

     

    Now Read This: Johnson & Johnson, Tesla And 3 Stocks To Watch Heading Into Thursday

    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $AKU
    $ALPS
    $AULT

    CompanyDatePrice TargetRatingAnalyst
    Netflix Inc.
    $NFLX
    3/30/2026Mkt Perform
    Citizens
    Netflix Inc.
    $NFLX
    3/24/2026Hold → Buy
    Erste Group
    Netflix Inc.
    $NFLX
    3/18/2026$115.00Buy
    Citigroup
    Netflix Inc.
    $NFLX
    3/9/2026$105.00Equal Weight
    Wells Fargo
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Netflix Inc.
    $NFLX
    3/2/2026$115.00Equal Weight
    Barclays
    Netflix Inc.
    $NFLX
    3/2/2026$120.00Overweight
    Analyst
    Netflix Inc.
    $NFLX
    2/27/2026$115.00Outperform
    Evercore ISI
    More analyst ratings

    $ABVC
    $AKU
    $ALPS
    $AULT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Neumann Spencer Adam

    4 - NETFLIX INC (0001065280) (Issuer)

    4/3/26 4:07:32 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form 4 filed by Zhu Xiaotong

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/2/26 8:08:52 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Kilgore Leslie J

    4 - NETFLIX INC (0001065280) (Issuer)

    4/2/26 6:02:54 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ABVC
    $AKU
    $ALPS
    $AULT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens initiated coverage on Netflix

    Citizens initiated coverage of Netflix with a rating of Mkt Perform

    3/30/26 8:19:42 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Netflix upgraded by Erste Group

    Erste Group upgraded Netflix from Hold to Buy

    3/24/26 12:31:36 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Citigroup resumed coverage on Netflix with a new price target

    Citigroup resumed coverage of Netflix with a rating of Buy and set a new price target of $115.00

    3/18/26 8:24:18 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ABVC
    $AKU
    $ALPS
    $AULT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ABVC
    $AKU
    $ALPS
    $AULT
    SEC Filings

    View All

    Tesla Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Tesla, Inc. (0001318605) (Filer)

    4/2/26 9:07:13 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 144 filed by Netflix Inc.

    144 - NETFLIX INC (0001065280) (Subject)

    4/1/26 4:10:08 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form NT 10-K filed by Cosmos Health Inc.

    NT 10-K - Cosmos Health Inc. (0001474167) (Filer)

    4/1/26 7:29:43 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ABVC
    $AKU
    $ALPS
    $AULT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced that on April 1, 2026, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 31,625 shares of Puma common stock to five new non-executive employees. The awards were granted under Puma's 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards to new employees of Puma. The restricted stock unit awards vest over a three-year period, with one-third of the shares underlying the award vesting on the first anniversary of the award's vesting commencement date, April 1, 202

    4/2/26 5:15:00 PM ET
    $PBYI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tesla First Quarter 2026 Production, Deliveries & Deployments

    In the first quarter, we produced over 408,000 vehicles, delivered over 358,000 vehicles and deployed 8.8 GWh of energy storage products. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q1 2026   Production Deliveries Subject to operating lease accounting Model 3/Y 394,611 341,893 1% Other Models 13,775 16,130 2% Total 408,386 358,023 1% Tesla will post its financial results for the first quarter of 2026 after market close on Wednesday, April 22, 2026. At that time, Tesla will issue a brief advisory containin

    4/2/26 9:03:00 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Richardson Electronics Announces Date of Third Quarter Fiscal Year 2026 Conference Call

    LAFOX, Ill., April 01, 2026 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ:RELL) plans to release its financial results for its third quarter ended February 28, 2026 after the close of business on Wednesday, April 8, 2026. The release will be distributed by GlobeNewswire and will be available on the Company's website at www.rell.com. On Thursday, April 9, 2026, at 9:00 a.m. Central Time, Edward J. Richardson, Chairman and Chief Executive Officer, and Robert J. Ben, Chief Financial Officer, will host a conference call to discuss the Company's third quarter fiscal year 2026 results. A question-and-answer session will be included as part of the call's agenda. Participant Instructi

    4/1/26 4:15:00 PM ET
    $RELL
    Electronic Components
    Technology

    $ABVC
    $AKU
    $ALPS
    $AULT
    Financials

    Live finance-specific insights

    View All

    Tesla First Quarter 2026 Production, Deliveries & Deployments

    In the first quarter, we produced over 408,000 vehicles, delivered over 358,000 vehicles and deployed 8.8 GWh of energy storage products. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q1 2026   Production Deliveries Subject to operating lease accounting Model 3/Y 394,611 341,893 1% Other Models 13,775 16,130 2% Total 408,386 358,023 1% Tesla will post its financial results for the first quarter of 2026 after market close on Wednesday, April 22, 2026. At that time, Tesla will issue a brief advisory containin

    4/2/26 9:03:00 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Richardson Electronics Announces Date of Third Quarter Fiscal Year 2026 Conference Call

    LAFOX, Ill., April 01, 2026 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ:RELL) plans to release its financial results for its third quarter ended February 28, 2026 after the close of business on Wednesday, April 8, 2026. The release will be distributed by GlobeNewswire and will be available on the Company's website at www.rell.com. On Thursday, April 9, 2026, at 9:00 a.m. Central Time, Edward J. Richardson, Chairman and Chief Executive Officer, and Robert J. Ben, Chief Financial Officer, will host a conference call to discuss the Company's third quarter fiscal year 2026 results. A question-and-answer session will be included as part of the call's agenda. Participant Instructi

    4/1/26 4:15:00 PM ET
    $RELL
    Electronic Components
    Technology

    NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results

    Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck cancer and lung cancerClinical results reported across multiple tumor types including esophageal cancer, pancreatic cancer, melanoma, head and neck cancer, and lung cancer that supported the broad potential of JNJ-1900 (NBTXR3) across solid tumors treated with radiotherapy next to the completion of the transfer of sponsorship for NANORAY-312Strengthened financial position through the closing of a non-dilutive royalty financing with HealthCare Royalty for up to $71 million and an amendment to the gl

    3/31/26 4:15:00 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $AKU
    $ALPS
    $AULT
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

    Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75%NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Holds valuable non-core strategic real estate and digital assets with an estimated fair market value exceeding $18 million, providing meaningful balance sheet flexibilityEvaluating potential monetization

    3/19/26 12:45:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Richardson Electronics' Canvys Division Appoints Rainer Bornwasser as VP of Global Sales

    LAFOX, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ:RELL), today announced that Rainer Bornwasser has been appointed Vice President of Global Sales for Canvys – Visual Technology Solutions, a division of Richardson Electronics, effective February 1, 2026. The appointment underscores Richardson Electronics' commitment to accelerating global growth, expanding strategic OEM partnerships, and strengthening its position in high-value medical and industrial display markets through its Canvys division. For conference questions and registration information, please contact your Benchmark representative. Mr. Bornwasser brings more than 30 years of international sales

    2/3/26 11:00:00 AM ET
    $RELL
    Electronic Components
    Technology

    $ABVC
    $AKU
    $ALPS
    $AULT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ABVC BioPharma Inc.

    SC 13G/A - ABVC BIOPHARMA, INC. (0001173313) (Subject)

    11/14/24 7:33:18 PM ET
    $ABVC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Netcapital Inc.

    SC 13G/A - Netcapital Inc. (0001414767) (Subject)

    11/14/24 7:25:20 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Cosmos Health Inc.

    SC 13G/A - Cosmos Health Inc. (0001474167) (Subject)

    11/14/24 4:50:24 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care